The Motley Fool··Matthew BenjaminEli Lilly Acquires Orna Therapeutics for $2.4B to Expand Gene Therapy Pipeline
Eli Lilly acquires Orna Therapeutics for $2.4B to gain circular RNA gene therapy technology and autoimmune disease candidates, strengthening its pipeline.
MRKLLYacquisitionclinical trials